Deals
Cancer Drugmaker Mirati Draws Fresh Takeover Interest
- Large pharmaceutical companies study merits of potential deal
- Possible buyers are awaiting data expected next month
Mirati Therapeutics Inc. headquarters in California
Source: Mirati Therapeutics Inc.
This article is for subscribers only.
Cancer drugmaker Mirati Therapeutics Inc. is attracting fresh takeover interest from large pharmaceutical companies ahead of updates on its drug pipeline, people with knowledge of the matter said. The stock rose as much as 16% on the news.
The San Diego-based company has been weighing strategic options including a potential sale for some time, said the people, who asked to not be identified because the matter isn’t public.